SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology EquipmentBio Process

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2169351

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2169351

Upstream Bioprocessing Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 280 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 7295
Printable PDF & Excel (Enterprise License above 5 users)
USD 8495

Add to Cart

Description

Table of Contents

Introduction

Upstream bioprocessing covers the stages of biologic drug production in which living cells are grown and induced to make therapeutic proteins, antibodies, vaccines and other complex products. It spans cell line expansion, media preparation and cultivation in bioreactors or fermenters, supported by bags, containers, sensors, probes and filters that keep processes sterile and controlled. In 2026, the market is valued at US$36.1 Bn and is projected to reach US$92.23 Bn by 2033, registering a CAGR of 14.30%.

This rapid growth reflects the expanding role of biologics in modern medicine, including monoclonal antibodies, biosimilars and new modalities such as cell and gene therapies. Each of these requires large-scale or highly specialised cell culture capacity. Manufacturers are also changing how they produce biologics, moving from fed-batch toward perfusion and continuous processes, adopting chemically defined media and adding digital monitoring. Vendors are expanding single-use portfolios, pursuing acquisitions to offer integrated workflows and adding regional capacity to support customers closer to where medicines are made.

Market Insights

The market is assessed across three segmentation dimensions: product, use type and mode. Products include bioreactors and fermenters, cell culture products, bags and containers, sensors and probes, filters and others. Cell culture products such as media and supplements represent recurring consumable demand, while bioreactors anchor capital investment in new facilities and capacity expansions.

By use type, the market is divided into multi-use and single-use systems. Single-use technologies are gaining share because they reduce cleaning and validation work, lower contamination risk and allow faster changeovers between products. By mode, production is split between in-house manufacturing and outsourced work performed by contract development and manufacturing organisations. Several trends are reshaping operations. Producers are shifting from fed-batch to perfusion and continuous processes that increase productivity, moving toward chemically defined media for greater consistency, and adopting digital monitoring to control processes in real time. Suppliers are broadening single-use offerings, acquiring complementary businesses to deliver integrated workflows and building regional manufacturing and service capacity to shorten supply chains.

Drivers

Two high-impact drivers support demand. The first, acting over the long term, is the growth of biologics, biosimilars and new modalities. Biologic medicines now account for a large share of new drug approvals, and biosimilars are widening access as patents expire. These products need large-scale cell culture, and new therapies add demand for specialised systems.

The second high-impact driver, over the medium term, is the adoption of single-use and intensified processes. Single-use bioreactors cut the time and cost of cleaning and validation and reduce contamination risk, while process intensification raises output from existing facilities. Together, they allow manufacturers to build flexible capacity more quickly. Restraints balance these forces. High capital costs and shortages of skilled labour carry high impact over the medium term, since bioprocessing facilities are expensive and require specialised scientists and technicians. Supply chain risks, plastic waste from single-use systems and regulatory complexity form a medium-impact, short-term restraint, affecting reliability, sustainability goals and the speed of process changes.

Business Opportunity

Cell and gene therapy manufacturing represents a significant opportunity. These therapies often involve modified patient or donor cells, or viral vectors grown in cell culture, and they require specialised culture systems, media and materials designed for smaller batch sizes, closed processing and strict quality control. As more therapies move through clinical development toward commercial approval, demand is rising for scalable platforms that can support both personalised and allogeneic production models, creating room for suppliers with dedicated technologies and expertise.

A second opportunity arises from contract development and manufacturing expansion and emerging-market capacity. Contract manufacturers are building new facilities to serve biotech companies that prefer to outsource production, and countries such as India, China and South Korea are adding substantial biologics capacity. These investments create volume demand for complete upstream systems, from bioreactors and sensors to consumables and media. Vendors that can supply integrated packages, local technical support and reliable consumable supply are well placed to win long-term agreements with these growing manufacturers.

Region Analysis

North America leads the market with a 40.3% share in 2026. The region has the largest concentration of biopharmaceutical companies, a deep pipeline of biologics and cell and gene therapies, and extensive manufacturing infrastructure. Strong research funding, an active venture capital environment and many contract manufacturers support continued investment in upstream capacity and advanced technologies.

Asia Pacific is the fastest-growing region, advancing at a 17.1% CAGR through 2033. Rapid expansion of biologics and biosimilar production, growing contract manufacturing capacity and government support for life sciences in countries such as India, China and South Korea are driving demand for upstream equipment and consumables. Europe is a major market with established biopharmaceutical producers, strong biosimilar adoption and significant investment in cell and gene therapy manufacturing. Latin America shows growing interest as countries develop local biologics and vaccine production to improve supply security. The Middle East and Africa remains a smaller market, with demand linked to vaccine manufacturing initiatives and efforts to build regional pharmaceutical capacity.

Key Players

  • Thermo Fisher Scientific
  • Danaher (Cytiva)
  • Sartorius
  • Merck KGaA
  • Lonza
  • Corning
  • Eppendorf
  • Repligen
  • Getinge
  • PBS Biotech

Segmentation

By Product:

  • Bioreactors & Fermenters
  • Cell Culture Products
  • Bags & Containers
  • Sensors & Probes
  • Filters
  • Others

By Use Type:

  • Multi-use
  • Single-use

By Mode:

  • In-house
  • Outsourced

By Geographic Coverage:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Upstream Bioprocessing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Upstream Bioprocessing Market Outlook, 2020 - 2033

  • 3.1. Global Upstream Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 3.1.1. Bioreactors & Fermenters
    • 3.1.2. Cell Culture Products
    • 3.1.3. Bags & Containers
    • 3.1.4. Sensors & Probes
    • 3.1.5. Filters
    • 3.1.6. Others
  • 3.2. Global Upstream Bioprocessing Market Outlook, by Use Type, Value (US$ Bn), 2020-2033
    • 3.2.1. Multi-use
    • 3.2.2. Single-use
  • 3.3. Global Upstream Bioprocessing Market Outlook, by Mode, Value (US$ Bn), 2020-2033
    • 3.3.1. In-house
    • 3.3.2. Outsourced
  • 3.4. Global Upstream Bioprocessing Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.4.1. North America
    • 3.4.2. Europe
    • 3.4.3. Asia Pacific
    • 3.4.4. Latin America
    • 3.4.5. Middle East & Africa

4. North America Upstream Bioprocessing Market Outlook, 2020 - 2033

  • 4.1. North America Upstream Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 4.1.1. Bioreactors & Fermenters
    • 4.1.2. Cell Culture Products
    • 4.1.3. Bags & Containers
    • 4.1.4. Sensors & Probes
    • 4.1.5. Filters
    • 4.1.6. Others
  • 4.2. North America Upstream Bioprocessing Market Outlook, by Use Type, Value (US$ Bn), 2020-2033
    • 4.2.1. Multi-use
    • 4.2.2. Single-use
  • 4.3. North America Upstream Bioprocessing Market Outlook, by Mode, Value (US$ Bn), 2020-2033
    • 4.3.1. In-house
    • 4.3.2. Outsourced
  • 4.4. North America Upstream Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.4.1. U.S. Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 4.4.2. U.S. Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 4.4.3. U.S. Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 4.4.4. Canada Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 4.4.5. Canada Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 4.4.6. Canada Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
  • 4.5. BPS Analysis/Market Attractiveness Analysis

5. Europe Upstream Bioprocessing Market Outlook, 2020 - 2033

  • 5.1. Europe Upstream Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 5.1.1. Bioreactors & Fermenters
    • 5.1.2. Cell Culture Products
    • 5.1.3. Bags & Containers
    • 5.1.4. Sensors & Probes
    • 5.1.5. Filters
    • 5.1.6. Others
  • 5.2. Europe Upstream Bioprocessing Market Outlook, by Use Type, Value (US$ Bn), 2020-2033
    • 5.2.1. Multi-use
    • 5.2.2. Single-use
  • 5.3. Europe Upstream Bioprocessing Market Outlook, by Mode, Value (US$ Bn), 2020-2033
    • 5.3.1. In-house
    • 5.3.2. Outsourced
  • 5.4. Europe Upstream Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.4.1. Germany Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 5.4.2. Germany Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 5.4.3. Germany Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 5.4.4. Italy Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 5.4.5. Italy Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 5.4.6. Italy Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 5.4.7. France Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 5.4.8. France Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 5.4.9. France Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 5.4.10. U.K. Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 5.4.11. U.K. Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 5.4.12. U.K. Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 5.4.13. Spain Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 5.4.14. Spain Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 5.4.15. Spain Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 5.4.16. Russia Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 5.4.17. Russia Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 5.4.18. Russia Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 5.4.19. Rest of Europe Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 5.4.20. Rest of Europe Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 5.4.21. Rest of Europe Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
  • 5.5. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Upstream Bioprocessing Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Upstream Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 6.1.1. Bioreactors & Fermenters
    • 6.1.2. Cell Culture Products
    • 6.1.3. Bags & Containers
    • 6.1.4. Sensors & Probes
    • 6.1.5. Filters
    • 6.1.6. Others
  • 6.2. Asia Pacific Upstream Bioprocessing Market Outlook, by Use Type, Value (US$ Bn), 2020-2033
    • 6.2.1. Multi-use
    • 6.2.2. Single-use
  • 6.3. Asia Pacific Upstream Bioprocessing Market Outlook, by Mode, Value (US$ Bn), 2020-2033
    • 6.3.1. In-house
    • 6.3.2. Outsourced
  • 6.4. Asia Pacific Upstream Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.4.1. China Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 6.4.2. China Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 6.4.3. China Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 6.4.4. Japan Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 6.4.5. Japan Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 6.4.6. Japan Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 6.4.7. South Korea Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 6.4.8. South Korea Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 6.4.9. South Korea Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 6.4.10. India Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 6.4.11. India Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 6.4.12. India Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 6.4.13. Southeast Asia Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 6.4.14. Southeast Asia Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 6.4.15. Southeast Asia Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 6.4.16. Rest of SAO Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 6.4.17. Rest of SAO Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 6.4.18. Rest of SAO Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
  • 6.5. BPS Analysis/Market Attractiveness Analysis

7. Latin America Upstream Bioprocessing Market Outlook, 2020 - 2033

  • 7.1. Latin America Upstream Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 7.1.1. Bioreactors & Fermenters
    • 7.1.2. Cell Culture Products
    • 7.1.3. Bags & Containers
    • 7.1.4. Sensors & Probes
    • 7.1.5. Filters
    • 7.1.6. Others
  • 7.2. Latin America Upstream Bioprocessing Market Outlook, by Use Type, Value (US$ Bn), 2020-2033
    • 7.2.1. Multi-use
    • 7.2.2. Single-use
  • 7.3. Latin America Upstream Bioprocessing Market Outlook, by Mode, Value (US$ Bn), 2020-2033
    • 7.3.1. In-house
    • 7.3.2. Outsourced
  • 7.4. Latin America Upstream Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.4.1. Brazil Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 7.4.2. Brazil Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 7.4.3. Brazil Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 7.4.4. Mexico Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 7.4.5. Mexico Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 7.4.6. Mexico Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 7.4.7. Argentina Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 7.4.8. Argentina Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 7.4.9. Argentina Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 7.4.10. Rest of LATAM Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 7.4.11. Rest of LATAM Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 7.4.12. Rest of LATAM Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
  • 7.5. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Upstream Bioprocessing Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Upstream Bioprocessing Market Outlook, by Product, Value (US$ Bn), 2020-2033
    • 8.1.1. Bioreactors & Fermenters
    • 8.1.2. Cell Culture Products
    • 8.1.3. Bags & Containers
    • 8.1.4. Sensors & Probes
    • 8.1.5. Filters
    • 8.1.6. Others
  • 8.2. Middle East & Africa Upstream Bioprocessing Market Outlook, by Use Type, Value (US$ Bn), 2020-2033
    • 8.2.1. Multi-use
    • 8.2.2. Single-use
  • 8.3. Middle East & Africa Upstream Bioprocessing Market Outlook, by Mode, Value (US$ Bn), 2020-2033
    • 8.3.1. In-house
    • 8.3.2. Outsourced
  • 8.4. Middle East & Africa Upstream Bioprocessing Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.4.1. GCC Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 8.4.2. GCC Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 8.4.3. GCC Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 8.4.4. South Africa Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 8.4.5. South Africa Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 8.4.6. South Africa Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 8.4.7. Egypt Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 8.4.8. Egypt Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 8.4.9. Egypt Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 8.4.10. Nigeria Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 8.4.11. Nigeria Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 8.4.12. Nigeria Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
    • 8.4.13. Rest of Middle East Upstream Bioprocessing Market Outlook, by Product, 2020-2033
    • 8.4.14. Rest of Middle East Upstream Bioprocessing Market Outlook, by Use Type, 2020-2033
    • 8.4.15. Rest of Middle East Upstream Bioprocessing Market Outlook, by Mode, 2020-2033
  • 8.5. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Danaher (Cytiva)
    • 9.4.3. Sartorius
    • 9.4.4. Merck KGaA
    • 9.4.5. Lonza
    • 9.4.6. Corning
    • 9.4.7. Eppendorf
    • 9.4.8. Repligen
    • 9.4.9. Getinge
    • 9.4.10. PBS Biotech

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!